ABSTRACT
Children from birth to 14 years of age with American tegumentary leishmaniasis were monitored at the Foundation for Tropical Medicine in the State of Amazonas, Brazil, from January to December 2005; 147 cases were recorded, 55.78% of which were male and 48.3% from the Rio Preto da Eva district. For 90 patients (67.67%), parents or guardians were interviewed about housing in the area where the infection was presumably acquired and the child's habits. Of the group, 58.89% of the children lived in the presumed area of infection, 60% customarily entered the forest with their parents, 91.11% lived in households with domestic animals, 77.78% of the residences were located within 100 meters of the forest; and 76.67% of the patients had at least one relative with a history of American tegumentary leishmaniasis. The transmission pattern was related to activities in the forest around the houses and the living situation near the primary forest, with cases of American tegumentary leishmaniasis found in very young children, suggesting transmission in and around the house, and in a few cases, children entering the forest.
Subject(s)
Endemic Diseases , Leishmaniasis, Cutaneous/epidemiology , Adolescent , Adult , Age Distribution , Animals , Animals, Domestic , Brazil/epidemiology , Chi-Square Distribution , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Leishmaniasis, Cutaneous/transmission , Male , Prospective Studies , Residence Characteristics , Surveys and Questionnaires , TreesABSTRACT
Relatamos pela primeira vez na Amazônia Brasileira um paciente com febre tifóide, com resistência clínica e laboratorial ao cloranfenicol, droga de escolha para esta doença em nossa regiäo. A recaída foi observada no 7° dia após o término do tratamento e a paciente foi tratada com ciprofloxacina
Subject(s)
Child , Female , Humans , Anti-Infective Agents/therapeutic use , Chloramphenicol/therapeutic use , Ciprofloxacin/therapeutic use , Salmonella typhi/drug effects , Typhoid Fever/drug therapy , Chloramphenicol Resistance , RecurrenceABSTRACT
We report for the first time in the Brazilian Amazon a typhoid fever patient with clinical and laboratorial resistance to chloramphenicol, drug of election for this disease in our region. The relapse was observed at the 7th day after the end of treatment and the patient was treated with ciprofloxacin.
